Skip to main content

Day: December 2, 2024

Certara Showcases 2024 Research Wins With Over 100 Papers Published

The company celebrates the 12 scientists included in the Stanford/Elsevier top 2% cited researchers list RADNOR, Pa., Dec. 02, 2024 (GLOBE NEWSWIRE) — Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today showcases its impact on research by celebrating more than 100 publications secured in 2024 as well as the 12 Certara scientists included on the 2024 Stanford/Elsevier list, which highlights the top 2% of the most cited scientists across the globe. Stanford/Elsevier’s Top 2% Scientist RankingNow in its 7th iteration, the Stanford/Elsevier’s Top 2% Scientist Ranking list includes the top and most-cited researchers globally in 22 scientific disciplines and 174 sub-disciplines and encompasses standardized data on citations, h-index, and a wide range of bibliometric indicators. The following...

Continue reading

Timbercreek Alternatives LP and Aspen Properties Close Acquisition of Calgary’s 1 Palliser Square Office Building to Commence Office-to-Residential Conversion Project

Companies also announce completion of private placement financing TORONTO, Dec. 02, 2024 (GLOBE NEWSWIRE) — Timbercreek Alternatives LP, a subsidiary of Timbercreek Capital, and Aspen Properties today announced the closing of the previously announced acquisition of the 1 Palliser Square Office Building in Calgary, Alberta for the purpose of converting approximately 418,000 square feet of office into 418 residential units and amenities. 1 Palliser Square is a 27-storey, vacant B-class office building centrally located next to the Calgary Tower, with direct access to residential amenities, entertainment and transit. The project is part of the City of Calgary’s Downtown Development Incentive Program designed to transform vacant office space into new rental housing stock. 1 Palliser Office-to-Residential Project Highlights:418 rental...

Continue reading

Zscaler Reports First Quarter Fiscal 2025 Financial Results

First Quarter HighlightsRevenue grows 26% year-over-year to $628.0 million Calculated billings grows 13% year-over-year to $516.7 million Deferred revenue grows 27% year-over-year to $1,783.7 million GAAP net loss of $12.1 million compared to GAAP net loss of $33.5 million on a year-over-year basis Non-GAAP net income of $124.3 million compared to non-GAAP net income of $86.4 million on a year-over-year basisSAN JOSE, Calif., Dec. 02, 2024 (GLOBE NEWSWIRE) — Zscaler, Inc. (Nasdaq: ZS), the leader in cloud security, today announced financial results for its first quarter of fiscal year 2025, ended October 31, 2024. “Growing customer engagements and strong sales execution drove a solid Q1 with all metrics exceeding our guidance. The combination of Zero Trust and AI is creating exciting new opportunities, which we are well positioned...

Continue reading

Credo Reports Second Quarter of Fiscal Year 2025 Financial Results

SAN JOSE, Calif., Dec. 02, 2024 (GLOBE NEWSWIRE) — Credo Technology Group Holding Ltd (Nasdaq: CRDO), an innovator in providing secure, high-speed connectivity solutions that deliver improved energy efficiency as data rates and corresponding bandwidth requirements increase through the data infrastructure market, today reported financial results for the second quarter of fiscal year 2025, ended November 2, 2024. Second Quarter of Fiscal Year 2025 Financial HighlightsRevenue of $72.0 million, grew by 20.6% quarter over quarter and 63.6% year over year GAAP gross margin of 63.2% and non-GAAP gross margin of 63.6%   GAAP operating expenses of $53.9 million and non-GAAP operating expenses of $37.6 million GAAP net loss of $(4.2) million and non-GAAP net income of $12.3 million GAAP diluted net loss per share of $(0.03) and non-GAAP...

Continue reading

Abacus Life Completes Acquisition of FCF Advisors

ORLANDO, Fla., Dec. 02, 2024 (GLOBE NEWSWIRE) — Abacus Life, Inc. (“Abacus” or the “Company”) (NASDAQ: ABL), a pioneering global alternative asset manager specializing in leveraging longevity data and actuarial technology to offer uncorrelated investment opportunities, today announced it has completed the acquisition of FCF Advisors (“FCF”), a New York-based asset manager and index provider specializing in free cash flow-focused investment strategies. The acquisition of FCF, which currently has approximately $850 million in assets under management, constitutes a significant milestone in Abacus’ ongoing expansion of ABL Wealth and its suite of products. “We are excited to complete this strategic acquisition and welcome FCF Advisors to the Abacus Life family,” said Jay Jackson, CEO of Abacus Life. “The addition of FCF Advisors significantly...

Continue reading

Nokia Corporation: Repurchase of own shares on 02.12.2024

Nokia CorporationStock Exchange Release2 December 2024 at 22:30 EET Nokia Corporation: Repurchase of own shares on 02.12.2024 Espoo, Finland – On 2 December 2024 Nokia Corporation (LEI: 549300A0JPRWG1KI7U06) has acquired its own shares (ISIN FI0009000681) as follows:Trading venue (MIC Code) Number of shares Weighted average price / share, EUR*XHEL 872,093 3.99CEUX – –BATE – –AQEU – –TQEX – –Total 872,093 3.99* Rounded to two decimals On 22 November 2024, Nokia announced that its Board of Directors is initiating a share buyback program to offset the dilutive effect of new Nokia shares issued to the shareholders of Infinera Corporation and certain Infinera Corporation share-based incentives. The repurchases in compliance with the Market Abuse Regulation (EU) 596/2014...

Continue reading

Optinose to Present at the Piper Sandler 36th Annual Healthcare Conference

YARDLEY, Pa., Dec. 02, 2024 (GLOBE NEWSWIRE) — Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today announced that members of its management team will present a company overview and business update at the Piper Sandler 36th Annual Healthcare Conference on December 5, 2024 at 1:30 p.m. ET. To listen to a webcast of the presentation live, please visit the Investors page of the Optinose website. A replay of the webcast will be available for 30 days following the conclusion of the event. About OptinoseOptinose is a specialty pharmaceutical company focused on serving the needs of patients cared for by ear, nose and throat (ENT) and allergy specialists. To learn more, please visit www.optinose.com or follow us on X and LinkedIn. Optinose Investor ContactJonathan...

Continue reading

Eagle Bancorp to Participate in the Jefferies Bank Summit

Bethesda, MD, Dec. 02, 2024 (GLOBE NEWSWIRE) — Eagle Bancorp, Inc., (the “Company”) (NASDAQ: EGBN), the Bethesda-based holding company of EagleBank, one of the largest community banks in the Washington D.C. area, today announced that Susan G. Riel, President and Chief Executive Officer and Eric R. Newell, Executive Vice President and Chief Financial Officer will participate in the Jefferies Bank Summit on December 9, 2024, and will hold a series of meetings with institutional investors. Management discussion materials to be used at this conference are posted on the investor section at Eagle Bancorp’s Investor Relations website at https://ir.eaglebankcorp.com. About Eagle Bancorp: The Company is the holding company for EagleBank, which commenced operations in 1998. The Bank is headquartered in Bethesda, Maryland, and operates through...

Continue reading

Almadex Provides Exploration Update, Commences Geophysical Surveys at Pilot and Paradise-Davis Project, Nevada

Paradise-Davis Property MapParadise-Davis Property MapVANCOUVER, British Columbia, Dec. 02, 2024 (GLOBE NEWSWIRE) — Almadex Minerals Ltd. (“Almadex” or the “Company”) (TSX-V: “DEX”) is pleased to provide an update on its western USA exploration activities. The Company has completed a planned drill hole at the north end of the Sinter Zone at its Paradise-Davis Project, Nevada. Drilling conditions were challenging as the hole hit an unexpected fault zone. This faulting has clearly moved geologic units at the north end of the trend of epithermal veining. Drilling has ceased for 2024 and further work will be planned after all results have been received and interpreted. The Sinter Zone covers an area of high-level epithermal alteration and veining as described in more detail below. Mapping of alteration...

Continue reading

Sun Communities, Inc. Declares Fourth Quarter 2024 Distribution

Southfield, MI, Dec. 02, 2024 (GLOBE NEWSWIRE) — Sun Communities, Inc. (NYSE: SUI) (the “Company”), a real estate investment trust (“REIT”) that owns and operates, or has an interest in, manufactured housing (“MH”) and recreational vehicle (“RV”) communities and marinas (collectively, the “properties”), today announced its Board of Directors declared a quarterly distribution of $0.94 per share of common stock for the fourth quarter of 2024. The distribution is payable on January 15, 2025 to shareholders of record on December 31, 2024. About Sun Communities, Inc. Sun Communities, Inc. is a REIT that, as of September 30, 2024, owned, operated, or had an interest in a portfolio of 659 developed properties comprising approximately 179,130 developed sites and approximately 48,760 wet slips and dry storage spaces in the United...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.